Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Times Uzbekistan.
Press releases published on September 25, 2025
Newsmatics to Showcase the Evolution of Press Releases for Boosting AI Reach at MarCom Summit
Company executives will demonstrate how an effective press release can boost a brand’s visibility in AI platforms WASHINGTON , DC, UNITED STATES, September 25, 2025 /EINPresswire.com/ -- Getting your press releases in front of journalists is valuable, …
ZenaTech firma oferta para adquirir empresa de topografía de Colorado, expandiendo su negocio nacional de Drones como Servicio (DaaS) a un mercado de topografía y cartografía de 36 mil millones de dólares en Estados Unidos
VANCOUVER, Columbia Británica, Sept. 25, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), proveedor de soluciones de tecnológicas empresariales, especializado en drones con inteligencia artificial (IA), Drone como …
NextGen Digital Platforms Inc. Announces Approval of Change of Business
Vancouver, B.C., Sept. 25, 2025 (GLOBE NEWSWIRE) -- NextGen Digital Platforms Inc. (CSE:NXT) (OTCQB:NXTDF) (FSE:Z12) (“NextGen” or the “Company”) a digital asset and fintech platform bridging traditional capital markets with Web3 infrastructure, is pleased …
Crinetics Announces FDA Approval of PALSONIFY™ (paltusotine) for the Treatment of Adults with Acromegaly
Novel nonpeptide SST2 agonist PALSONIFY advances the treatment paradigm as the first once-daily, oral therapy approved by the FDA to treat acromegaly Approval based on data from two pivotal Phase 3 trials where PALSONIFY was well tolerated and resulted in …
Kura Oncology and Kyowa Kirin Announce Publication of Pivotal Ziftomenib Data in Relapsed/Refractory NPM1-Mutated AML in the Journal of Clinical Oncology
– KOMET-001 in R/R NPM1-m AML met its primary endpoint with ziftomenib monotherapy demonstrating significant clinical benefit and deep responses – – Consistent activity across pre-specified subgroups, regardless of prior HSCT, prior venetoclax, lines of …
Global Technology Manufacturer Selects Kneat to Drive Digital Transformation Across Enterprise and Manufacturing Sites
LIMERICK, Ireland, Sept. 25, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQC: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that a leading multinational manufacturer of advanced devices …
Medicenna Announces Results of Annual Meeting of Shareholders
TORONTO and HOUSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines, today announced the voting …
Organogenesis Provides Update on Second Phase 3 ReNu® Study
Company maintains confidence in ReNu as innovative pain management therapy Second Phase 3 trial demonstrates numerical improvement in baseline pain reduction over the first Phase 3 trial despite not meeting the primary endpoint Statistically significant …
Teva to Host Conference Call to Discuss Third Quarter 2025 Financial Results at 8 a.m. ET on November 5, 2025
TEL AVIV, Israel, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its third quarter 2025 financial results on Wednesday, November 5, 2025, at 7:00 a.m. ET. …
Buying Guide 2025- most effective female libido booster pills in 2025 By OhYes
Washington Dc, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Oh Yes, a leading name in women’s sexual wellness, is proud to introduce its latest breakthrough in female libido enhancement — a scientifically formulated supplement designed to reignite desire, amplify …
Mercury Selected to Develop Cockpit Communications Subsystem for New U.S. Military Aircraft
ANDOVER, Mass., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Mercury Systems, Inc. (NASDAQ: MRCY, www.mrcy.com), a global technology company that delivers mission-critical processing to the edge, today announced it received a $12.3 million development contract from …
Harrow Launches Harrow Access for All (HAFA)
HAFA to Expand Harrow’s Innovative Market Access Model Across Ophthalmic Portfolio Program will be available in late 2025 through the HarrowAccess.com Portal NASHVILLE, Tenn., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of …
Cidara Therapeutics Announces First Participants Dosed in Phase 3 ANCHOR Trial Evaluating CD388 for the Prevention of Seasonal Influenza in High-Risk Populations
- Phase 3 study expected to enroll 6,000 participants starting in the Northern Hemisphere - Participants will include adults over 65 years of age in addition to individuals with high-risk co-morbidities and immune compromised status SAN DIEGO, Sept. 25, …
Buying Guide 2025- Pills to Increase Sex Drive Female 2025 -Start Your Libido Life Today with Oh yes
washington DC, Sept. 25, 2025 (GLOBE NEWSWIRE) -- In 2025, women’s sexual wellness takes center stage. OhYesBashed proudly announces the launch of its definitive Buying Guide 2025 – Pills to Increase Sex Drive for Women, a breakthrough resource designed to …
Scilex Holding Company Announces $150 Million Strategic Bitcoin Investment in Datavault AI
PALO ALTO, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for …
DIAGNOS Announces Voting Results of Meeting of Shareholders
BROSSARD, Quebec, Sept. 25, 2025 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using Artificial Intelligence (AI) technologies, …
DIAGNOS annonce le résultat du vote à l'assemblée annuelle des actionnaires
BROSSARD, Québec, 25 sept. 2025 (GLOBE NEWSWIRE) -- Diagnos inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK, OTCQB : DGNOF, FWB : 4D4A), un pionnier dans l’utilisation de l'intelligence artificielle (IA) pour la détection précoce de …
SoCalBio Investor Conference Sessions to Spotlight Bioscience Workforce Development, Technology Transfer, and AI-Driven Innovation
LOS ANGELES, Sept. 25, 2025 (GLOBE NEWSWIRE) -- The Southern California Biomedical Council (SoCalBio) today announced the final lineup of expert panels for its 27th Annual Investor …